Welcome Back

Welcome Back

The holiday-shortened week began in predictable fashion, with equities climbing the proverbial "wall of worry" as daunting virus headlines and Donald Trump's dangerously quixotic efforts to usurp American democracy were brushed aside in favor of "vaccine optimism," which is now the generic, go-to excuse for anyone who needs to "explain" higher stock prices. On Monday evening, Emily Murphy, the administrator of the General Services Administration, formally began the transition to the Joe Biden a
Subscribe or log in to read the rest of this content.

9 thoughts on “Welcome Back

  1. “But don’t get too excited if you’re the proletariat or labor more generally.” I’m skeptical that much of the proletariat is getting their economic updates via the HB Report. One never knows though.

  2. This was a Report I forwarded to some of my fiscally “conservative” investor friends.

    Sometimes I use H’s Reports as a way to say that I don’t want to take all their stuff and
    hand it out to the lazy homeless population in Seattle.

  3. Be careful comparing the efficacy of the various vaccines. You may be comparing apples to oranges.

    The Pfizer and Moderna studies only tested symptomatic patients for COVID when they were counting cases. The AstraZeneca studies tested ALL patients weekly, so they included asymptomatic patients in their totals while Pfizer and Moderna didn’t.

    I suspect the vaccines from all three have statistically similar efficacies once adjusted for the difference in methodologies.

Speak your mind

This site uses Akismet to reduce spam. Learn how your comment data is processed.